|
Temps réel estimé
Cboe BZX
17:40:14 28/10/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 224,82 USD | -0,87% |
|
-0,01% | -43,40% |
| 26/10 | Transcript : Alnylam Pharmaceuticals, Inc. - Special Call | |
| 23/10 | Alnylam Pharmaceuticals fait état d’une réduction de 60 % à 64 % de la huntingtine dans l’essai sur le brezosiran | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,87% | -0,01% | -11,86% | -21,96% | -43,40% | -52,71% | +48,65% | +38,81% | +519,35% | 30,35 Md | |
| +0,51% | +1,22% | +8,57% | +5,38% | +19,69% | +56,84% | +127,37% | +407,71% | +1 625,86% | 1 143 Md | |
| +0,79% | +4,78% | -0,68% | +1,26% | +30,51% | +44,49% | +83,70% | +65,86% | +134,20% | 647 Md | |
| +0,21% | +0,64% | +7,64% | +8,90% | +25,45% | +25,97% | +102,01% | +161,36% | +397,63% | 506 Md | |
| -0,35% | +1,43% | +11,87% | +8,07% | +21,15% | +52,28% | +64,77% | +11,43% | +73,02% | 384 Md | |
| -0,80% | -6,42% | -5,67% | +6,40% | +33,25% | +61,16% | +36,60% | +62,06% | +138,38% | 350 Md | |
| +0,40% | +1,89% | +6,49% | -0,86% | +17,96% | +30,76% | +52,76% | +68,95% | +81,83% | 293 Md | |
| -0,21% | +1,40% | +2,39% | -1,16% | -7,25% | +3,10% | +25,17% | +41,17% | +177,02% | 265 Md | |
| +0,49% | +2,57% | +7,53% | +14,37% | +37,36% | +53,93% | +70,83% | +117,02% | +209,68% | 242 Md | |
| +0,30% | +3,66% | +4,58% | +18,51% | +29,69% | +35,04% | +104,69% | +136,39% | +115,46% | 197 Md | |
| -1,73% | -2,56% | +1,09% | -23,97% | -21,60% | -23,03% | -62,37% | -26,05% | +114,74% | 171 Md | |
| -1,66% | -1,62% | +2,25% | +16,30% | +17,93% | +19,86% | -3,88% | -31,99% | -8,03% | 170 Md | |
| +1,15% | +0,26% | -0,34% | +7,24% | +16,00% | +24,51% | +47,13% | +188,96% | +577,88% | 132 Md | |
| -1,83% | -1,15% | -5,42% | -5,00% | +12,01% | +41,10% | +17,89% | +5,76% | +18,47% | 126 Md | |
| -0,59% | -5,31% | +12,29% | +8,10% | +17,22% | +19,51% | +113,95% | +369,01% | +674,77% | 113 Md | |
| -5,20% | -2,34% | -1,92% | -10,09% | -0,01% | +10,97% | +25,61% | -2,64% | -10,33% | 103 Md | |
| +0,48% | +2,64% | +4,88% | -4,88% | -8,72% | -13,46% | -10,26% | -12,19% | +5,71% | 100 Md | |
| -0,51% | +0,62% | +7,77% | +16,62% | +5,03% | +23,87% | +4,25% | +29,67% | +127,83% | 81,49 Md | |
| +3,37% | -12,79% | +8,66% | +284,12% | +626,89% | +745,60% | +189,40% | -38,39% | - | 83,03 Md | |
| -1,11% | +2,86% | -0,03% | -3,42% | -19,76% | -2,55% | +48,03% | +53,81% | +470,17% | 69,7 Md | |
| Moyenne | -0,35% | -0,24% | +3,00% | +16,20% | +40,47% | +57,86% | +54,32% | +82,34% | +286,51% | 260,32 Md | |
| Moyenne pondérée par Capi. | -0,00% | +0,32% | +4,53% | +8,80% | +28,22% | +48,03% | +73,27% | +146,49% | +507,11% |
- Bourse
- Actions
- Action ALNY
- Secteur Alnylam Pharmaceuticals, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
